Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUFFEN: Echogenic vs Standard Needles for Femoral Nerve Block
NCT02046317Phase 4Terminated
- Sponsor
- UTHealth Houston
- Start
- May 2011
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
Phase 4, randomised trial (2 arms), sponsored by UTHealth Houston. Primary endpoint: Patient Pain Level at 60 months. Started May 2011; status: terminated.
Beyond the preview
Go deeper on NCT02046317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046317.